Gary W. Pace, Director at Pacira BioSciences, Inc. (PCRX), sold 147,580 shares at $30.81 ($4.5M) on 2024-03-07, disclosed to the SEC on 2024-03-08.
Open-market sale of $4.5M PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.67 | 1,066 | $32K | 0.7% |
| 2 | $30.81 | 28,257 | $871K | 19.2% |
| 3 | $30.81 | 28,257 | $871K | 19.2% |
| 4 | $30.60 | 90,000 | $2.8M | 60.8% |
| Total | $30.67 avg | 147,580 | $4.5M | 100% |
| Filing → |
| CRDF | BUY | 2025-07-31 | $711K | — | Filing → |
| CRDF | BUY | 2024-12-12 | $940K | — | Filing → |
| CRDF | BUY | 2023-12-19 | $41K | — | Filing → |